Table 1.
Pharmacokinetic parameters for midazolam after intravenous and subcutaneous administration of a 0.1 mg kg−1 dose to healthy volunteers (n = 18) over 5 min. Values are geometric means (± s.d.).
Pharmacokinetic parameters | i.v. route | s.c. route |
---|---|---|
Cmax (ng ml−1) | 557.7 (261.6) | 127.8 (29.3)*** |
tmax (h) | 0.10 (0.03) | 0.51 (0.18)*** |
t1/2 (h) | 2.9 (0.7) | 3.2 (1.0)* |
AUC (0,t) (ng ml−1 h) | 383.8 (81.9) | 350.4 (71.8) |
AUC (0,∞) (ng ml−1 h) | 400.1 (93.7) | 379.1 (88.2) |
F (%) | – | 96 (14) |
CL (ml min−1 kg−1) | 4.4 (1.0) | – |
V (l kg−1) | 1.1 (0.2) | – |
Statistically significant difference between the two ways of administration was established using anova (Cmax, t1/2) or Wilcoxon rank sum test (tmax)
P < 0.05
P < 0.0001.